Recognize CRVO 'blood and thunder' fundus

Central retinal vein occlusion is one of those diagnoses that becomes obvious once you’ve seen it once. The retina looks angry — hemorrhages in all four quadrants, veins engorged and tortuous, the disc swollen, sometimes cotton-wool spots scattered through the posterior pole. That’s the classic “blood and thunder” fundus. The stakes are simple: this can cost vision fast, and the real job in clinic is not just naming it but deciding how ischemic it is, how urgently it needs retina follow-up, and what complication is most likely to hurt the patient next. ### What are you actually seeing? You are seeing venous outflow failure in the retina. A thrombus in the central retinal vein — usually at or just behind the lamina cribrosa — causes venous congestion, rising intraluminal pressure, retinal hemorrhage, edema, and reduced perfusion. On fundus exam that becomes the familiar pattern: dilated tortuous veins, dot-blot and flame hemorrhages in all quadrants, optic-disc swelling, and often macular edema. (aao.org) ### Why “blood and thunder”? Because the whole posterior pole looks stormed over. This is not a small sectoral bleed like branch retinal vein occlusion. CRVO is diffuse. Four-quadrant hemorrhages are the visual clue, and the added venous tortuosity plus disc edema make the picture pop. If the macula is involved — and it often is — the patient notices sudden blurry vision or a central gray patch. ### What does the patient usually say? (nei.nih.gov) Usually: “I woke up and one eye got blurry.” It is classically acute, unilateral, and painless. Floaters can happen, but pain should make you think harder about another process or a complication like neovascular glaucoma later on. Visual loss can range from mild blur to profound loss, and that range matters because very poor acuity at presentation pushes you toward ischemic CRVO. (aao.org) ### What makes it ischemic? This is the key triage question. Ischemic CRVO is the dangerous version because it carries a much higher risk of anterior-segment neovascularization and neovascular glaucoma. Clues include very poor visual acuity, a relative afferent pupillary defect, extensive hemorrhages, many cotton-wool spots, marked disc swelling, and broad capillary nonperfusion on fluorescein angiography. Non-ischemic CRVO can still threaten vision — mostly through macular edema — but it is less likely to go on to the ugly neovascular complications. (aao.org) ### What else can mimic it? The main look-alikes are diabetic retinopathy, ocular ischemic syndrome, hypertensive retinopathy, and sometimes papillophlebitis in younger patients. The easiest sorting trick is distribution and context. CRVO is usually unilateral and dramatic. Diabetic retinopathy is often bilateral and more chronic. Ocular ischemic syndrome comes with carotid disease clues and a different hemorrhage pattern. If the patient is young, bilateral, recurrent, or otherwise atypical, that is when you widen the workup. (aao.org) ### What do you check right away? Visual acuity, pupils for RAPD, intraocular pressure, slit-lamp exam of the iris, and ideally gonioscopy if you’re worried about neovascularization. OCT matters because macular edema is the main treatable cause of vision loss. Fluorescein angiography helps when the ischemic status is unclear. Systemically, think hypertension, diabetes, hyperlipidemia, glaucoma or ocular hypertension, and smoking — the usual vascular suspects. (eyewiki.org) ### How is it treated now? The first-line treatment for vision loss from macular edema is intravitreal anti-VEGF therapy. Steroids are another option in selected patients, especially when anti-VEGF response is incomplete or injection burden is an issue, but they bring cataract and pressure tradeoffs. Laser is not a routine fix for CRVO macular edema; panretinal photocoagulation is mainly used once neovascularization appears, or sometimes when reliable follow-up is impossible and ischemic risk is high. (aao.org) ### Why does follow-up matter so much? Because the scary part can arrive after the first visit. Ischemic eyes can develop iris or angle neovascularization over the following weeks to months — the classic setup for neovascular glaucoma. So even if the diagnosis feels visually satisfying on day one, the real work is surveillance: repeat exams, watch the anterior segment, track OCT, and escalate treatment if neovascular changes show up. (eyewiki.org) The bottom line is that “blood and thunder” is not just a memorable fundus photo. It is a triage signal. Recognize the pattern, separate ischemic from non-ischemic disease, look hard for RAPD and neovascular risk, and get macular-edema treatment and close retina follow-up moving quickly. (aao.org)